Artemis Medicare Services Share price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,93,504 shares, with a market capitalization of ₹158306247. Its Average Traded Price (ATP) is ₹324.06, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 37 @ ₹323.70.
Artemis Medicare Services has an upper circuit limit of ₹394.65 and a lower circuit limit of ₹263.15. The total value traded stands at ₹6.27 CR, and the delivery percentage for the day is 50.41%.
The stock is currently traded with a market lot size of 1. Artemis Medicare Services also offers a dividend yield of 0.14%.
Artemis Medicare Services share price chart
Artemis Medicare Services Share Key Metrics
Volume
1.94 L
Market Cap
5124.37 CR
LTQ@LTP
37@323.70
ATP
324.06
Var Margin
18.72 %
Circuit Range
263.15-394.65
Delivery %
50.41 %
Value
6.27 CR
ASM/GSM
No
Market Lot
1
Artemis Medicare Services Resistance and Support
Pivot 329.53
Resistance
First Resistance
333.06
Second Resistance
337.23
Third Resistance
340.76
Support
First Support
325.36
Second Support
321.83
Third Support
317.66
Artemis Medicare Services Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Artemis Medicare Services Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-06-04 | Others |
| 2026-05-08 | Audited Results & Final Dividend |
| 2026-02-02 | Quarterly Results & Others |
| 2025-11-11 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-10 | 2026-07-10 | View More |
Artemis Medicare Services News
Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Artemis Medicare Services announced the availability of the audio recording from its Q1 FY27 earnings conference call. The call, held on August 4, 2026, discussed the company's operational and financial performance for the quarter.
Aug 04 2026 15:19:50
Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Artemis Medicare Services filed its Q1 FY27 Monitoring Agency Report for its Rs.330 crore preferential issue. The company utilized Rs.17.45 crore towards capex and expansion, but the overall project completion timeline has been extended by 18 months to November 2027.
Aug 03 2026 18:28:21
Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Artemis Medicare Services reported strong Q1 FY27 results. Consolidated revenue grew 12.7% YoY to Rs.287.32 cr, while net profit surged 48.3% YoY to Rs.31.44 cr. EBITDA also saw a significant increase of 27.9% YoY to Rs.61.82 cr, driven by strong operational performance.
Aug 03 2026 17:54:12
Artemis Medicare Services Ltd - 542919 - Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Artemis Medicare Services is undertaking a significant expansion of its flagship hospital in Gurugram, investing Rs. 160-180 crore to add over 200 beds within two years. This expansion aims to enhance quaternary pediatric and women's health services, addressing growing demand and supporting long-term revenue growth.
Aug 03 2026 17:41:48
Artemis Medicare Services Ltd - 542919 - Board Meeting Outcome for Board Meeting Held On August 3, 2026
Artemis Medicare Services' board approved Q1 FY27 consolidated financial results, with revenue rising 12.69% YoY to ₹287.32 crore and net profit increasing 48.33% YoY to ₹31.44 crore. The board also approved a ₹160-180 crore expansion for its Gurugram hospital, adding 200+ beds.
Aug 03 2026 17:16:04
Artemis Medicare Services Ltd - 542919 - Board Meeting Intimation for Consideration Of Un-Audited Financial Results
Artemis Medicare Services board will convene on August 3, 2026, to review and approve the unaudited financial results for Q1 FY27. This meeting is a routine quarterly disclosure.
Jul 29 2026 12:35:07
Artemis Medicare Services Management
| Name | Position |
|---|---|
| Poonam Makkar | Company Secretary & Compliance Officer |
| Onkar Kanwar | Chairman |
Artemis Medicare Services Similar Stocks
Bliss GVS Pharma Ltd.
561.50
-3.40 (0.60%)
Orchid Pharma Ltd.
1038.55
0.45 (0.04%)
FDC Ltd.
343.65
-0.65 (0.19%)
Morepen Laboratories Ltd.
93.90
-1.32 (1.39%)
Supriya Lifescience Ltd.
791.65
-5.50 (0.69%)
IOL Chemicals And Pharmaceuticals Ltd.
172.37
3.29 (1.95%)
RPG Life Sciences Ltd.
2584.50
-38.90 (1.48%)
Gufic Biosciences Ltd.
413.65
-4.35 (1.04%)
Aarti Drugs Ltd.
422.20
1.15 (0.27%)
Kwality Pharmaceuticals Ltd.
3373.10
-79.10 (2.29%)
Artemis Medicare Services FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ARTEMISMED
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in ARTEMISMED
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade